University of Minnesota
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Minnesota sits in the top decile of US sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count).
University of Minnesota: 966 sponsored US clinical trials, 180 recruiting.
University of Minnesota sponsors 966 registered US clinical trials on ClinicalTrials.gov, 180 of them currently recruiting, and 671 completed. 71 of these trials are in Phase 3-4 (later-stage) and 206 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 14 trials.
Top-decile sponsor footprint
University of Minnesota ranks in the top decile of sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
671 of 731 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
966 total, page 19 of 20
Anxiety Self-Management for ICU Patients Receiving Mechanical Ventilation
NCT00440700
An Intervention to Improve End of Life Decision Making Among Homeless Persons
NCT00471016
Alfuzosin Hydrochloride to Relieve Ureteral Stent Discomfort
NCT00467467
Cognitive Behavioral Therapy for Pathological Gambling
NCT00337753
Double-Blind Naltrexone in Kleptomania
NCT00332579
Women in Steady Exercise Research [Formerly Women, Oxidative Stress, Exercise and Estrogens (WOSEE)]
NCT00393172
Macrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated With Chronic Obstructive Pulmonary Disease
NCT00325897
Investigating the Anti-Human Immunodeficiency Virus (HIV) & Anti-inflammatory Effect of Chloroquine
NCT00308620
Comparison of Airway Clearance Efficacy of Two High Frequency Chest Wall Oscillation (HFCWO) Devices in Cystic Fibrosis
NCT00308958
A Phase I Study of Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.
NCT00332215
Environmental Intervention for Weight Gain Prevention
NCT00708461
An Open-Label Study Of Lamictal In Neurotic Excoriation
NCT00269594
An Open-Label Study of N-Acetyl Cysteine in Pathological Gambling
NCT00273702
PET Imaging and Olanzapine Treatment in Borderline Personality Disorder
NCT00275301
MGA031, Sirolimus and Tacrolimus in Islet Transplantation
NCT00265473
A Study of Factors That Affect Long-Term Kidney Transplant Function
NCT00270712
Effect of Paroxetine on Smokers' Cardiovascular Response to Stress - 1
NCT00218439
New Moves - Obesity Prevention Among Adolescent Girls
NCT00250497
Comprehensive Support for Alzheimer's Disease Caregivers
NCT00362284
Brief Intervention for Drug Abusing Adolescents
NCT00350909
Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi
NCT00177086
Effect of Nutrition Labeling on Fast Food Choices
NCT00127660
Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1
NCT00218179
Antihypertensive Treatment in Acute Cerebral Hemorrhage
NCT00415610
Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant
NCT00321932
Alefacept in Patients With Severe Scalp Alopecia Areata
NCT00167102
Impact of Sterilization Technique on Incidence of Urinary Tract Infection After Cystoscopy
NCT00177112
Promoting Physical Activity for Persons With Multiple Sclerosis
NCT00513448
Metabolic Syndrome in Childhood Cancer Survivors
NCT00920738
Functional Neuroimaging Effects of Cognitive Remediation Training
NCT00481156
Benefits of Lightweight Ambulatory Oxygen Systems for Individuals With Chronic Obstructive Pulmonary Disease
NCT00325754
MRI Imaging in Borderline Personality Disorder
NCT00275288
The Effect of Oxygen on Healing an Artery From the "Injury" of Surgery
NCT00863603
Measurement of Glucose/Glycogen Metabolism in Humans Using Magnetic Resonance at 4 or 7 Tesla
NCT00786825
Maintenance-Tailored Obesity Treatment
NCT00670462
Worksite Program to Prevent Weight Gain Among Bus Drivers
NCT00122993
Use of Campath for Induction and Maintenance Therapy in Pancreas After Kidney Transplantation
NCT00177138
A Pilot Study Comparing the Programmed Delay Between the Atrial and Ventricle Interval
NCT00794183
Prevention of Jellyfish Stings
NCT00114894
Dietary Fiber for Fecal Incontinence
NCT01738607
Controlled Trial of Valacyclovir in Infectious Mononucleosis
NCT00274404
Evaluating the Effect of the VCD on Erectile Function and Penile Length Post RRP
NCT00177125
Cerebral Responses to Insulin Induced Hypoglycemia
NCT02747680
Insulin Glargine Vs Standard Insulin Therapy
NCT00222521
Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation
NCT00286624
Obstetrics and Periodontal Therapy (OPT) Study
NCT00066131
Prediction of Medication Compliance Following Renal Transplantation
NCT00148187
Angiotensin II Blockade for Chronic Allograft Nephropathy
NCT00067990
Evaluating the Effectiveness of Early Cognitive Behavioral Therapy With or Without Parental Involvement in Treating Anxious Children
NCT00557648
A Comparative Study of New Medications for Psychosis in Adolescents
NCT00222495
What is open in the University of Minnesota pipeline
180 recruiting of 966 indexed (19% open); 671 completed (69%).
Phase mix: 71 late (III/IV) vs 206 early (I/II) (early-phase heavy).
Top condition: Obesity (14 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Minnesota: open-pipeline peers nationwide
Peers matched on 966 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Minnesota sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 966 trials (± recruiting share)
- Columbia University · 958 trials · 18% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Alabama at Birmingham · 19% recruiting · 1,160 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Minnesota page
966 registered trials is a research-attention snapshot, not an endorsement of University of Minnesota or any single study.
- 180 of University of Minnesota's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Minnesota studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Minnesota pipeline card: 966 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.